Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | R161Q |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | VHL R161Q lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). R161Q results in a partial loss of binding to HIF-OH and partial degradation of Hif2a in culture (PMID: 25371412), but has not been fully biochemically characterized and therefore, its effect on Vhl protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL R161Q |
Transcript | NM_000551.4 |
gDNA | chr3:g.10149805G>A |
cDNA | c.482G>A |
Protein | p.R161Q |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000551.4 | chr3:g.10149805G>A | c.482G>A | p.R161Q | RefSeq | GRCh38/hg38 |
NM_000551 | chr3:g.10149805G>A | c.482G>A | p.R161Q | RefSeq | GRCh38/hg38 |
NM_000551.3 | chr3:g.10149805G>A | c.482G>A | p.R161Q | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|